麻豆传媒

Geriatrics >

Hypertension

News, opinions and meeting coverage in geriatrics.

The Fake Hypertension War

Medical politics and mud fights

ACP Criticizes New Blood Pressure Guideline

Changes went too far on too little evidence, group says

One Workout May Protect Heart from Ischemia for Hours or Days

Evidence builds for immediate benefit from preconditioning

A Visual Guide to the New Blood Pressure Guidelines

The ACC/AHA 2017 recommendations -- in color and by the numbers

Move to Get Benicar Off Market; Nexterone Recall; Squirrel Hibernation Stroke Tx?

Recent developments of interest in cardiovascular medicine

AHA: BP Measurement in SPRINT Was All Over the Place

Did varying presence of staff during BP readings ruin a huge study?

AHA: Follow Same HTN Cutoff for Adults and Teens

But adult and pediatric hypertension guidelines differ in other respects

AHA: 130/80 mm Hg Is New National BP Target

Multisociety guidelines released accounting for SPRINT data

Borderline Pulmonary Hypertension Tied to Mortality Risk

Small increases in pressure might signal left heart failure, not early PAH

Entresto Boosts Sex in HF; Venom Antidote to Xa Drugs; Guilty Plea for FH Vagueness

Recent developments of interest in cardiovascular medicine

ESC: Top Videos from This Year's Meeting

Highlights include CANTOS history and a Houston cardiologist's take on the flood

ESC: No BP Spike Seen with Celecoxib Use

But ibuprofen boosts systolic pressure

CANTOS to Headline ESC

August's European Society of Cardiology meeting lineup released

Lower BP Targeted in New Heart Failure Guidelines

ACC/AHA/HFSA recommend adjusted SPRINT target of

Consistently High BP Seems to Up Dementia, AD Risk

Steep BP decrease among non-hypertensives also a concern

CardioBrief: SPRINT Leader Defends Controversial BP Trial

Debate continues over methods, meaning of 'landmark' trial

ACP: What's New in mHealth

Do apps promoting weight loss and heart health really work?

ACC: Online Videos Help HTN Adherence

Blood pressure, Framingham risk improved in small trial

CardioBrief: Int'l Experts Call Sodium Guidelines Far Too Restrictive

Conclusion: research more, recommend less

Slow Medicine: Is 'Hypertensive Urgency' Outdated?

No need to over-react to a common dx that's not tied to major CV events

CardioBrief: Cardiologists Give SPRINT Thumbs Down

Trial should not be used in guidelines to lower blood pressure targets

Compression Stockings; Stroke Prevention; Stents and Meds

Cardiovascular Daily wraps up the top cardiology news of the week

The American Heart Association's Stance Against Science

Group insists dietary sodium question is settled when it plainly isn't

CardioBrief: You Say Potato, I Say Worthless Epidemiology

Observational study links potatoes to high blood pressure

LAA Ligation as an Antihypertensive?

One study says yes, another says no

Blood Pressure Drop for CKD Patients on Patiromer

Sub-analyses finds those with resistant hypertension see benefits

ACC: TAVR Once Again Non-Inferior to Surgery

No excess stroke or mortality at 2 years in lowest risk trial population yet studied

ACC: HOPE Results Boost Statin Prevention Role

Mortality and nonfatal events reduced

Projected Uptravi Cost: $160-170K a Year

But new PAH drug is still cheaper than some alternatives

SPRINT v. ACCORD: Which Target Will Win in Diabetes?

Not such a no-brainer, hypertension experts say

CardioBrief: Dollars for Heart Docs

Analysis of CMS database shows some docs pocketed millions from drug and device makers.

ACC: Folate Supplements Cut Strokes in Hypertension

Hypertensive patients with low blood folate levels gain big benefit.

Patients Should Share Accountability for Own Health

A new report recommends doctors not be penalized for poor outcomes if patients fail to follow recommended protocols

HTN May Halt Dementia in Very Elderly

COPENHAGEN -- Among individuals who developed hypertension at age 90 or later, their risk of also developing dementia was dramatically lower than other very elderly people whose blood pressure remained normal.

FDA: No Clear Sign of Harm With Olmesartan in Diabetics

The evidence linking use of the angiotensin II receptor blocker (ARB) olmesartan in patients with diabetes and increased cardiovascular risk is not conclusive, according to a completed FDA safety review.

Urine Test Can Uncover BP Med Adherence

A simple urine test might help clinicians figure out whether their patients aren't responding to antihypertensive therapy because of true resistance or because of nonadherence, a small study suggested.

How to Replace IV Nitroglycerin in the Shortage

What are the alternatives for IV nitroglycerin in the emergency setting as the shortage saps reserves? Several experts share their thoughts.

Ob/Gyns Uneasy With AHA's Take on Stroke in Pregnancy

NEW ORLEANS -- Recent guidelines from the American Heart Association on the management of stroke risk in pregnant women differ significantly from those issued by the American Congress of Obstetricians and Gynecologists, maternal-fetal medicine specialists said here.

ACE Inhibitors Linked to Severe Allergic Reactions

BALTIMORE -- Antihypertensive treatment with ACE inhibitors may prime oral allergy syndrome patients for severe reactions, a case-report suggested.

Low BP May Be Fatal in CKD

Chronic kidney disease patients, including those with diabetes, who were not on dialysis were more likely to die when blood pressure was too low, even if only on the diastolic measure, a veterans cohort showed.

鈥�

6